Rapid Micro Biosystems (RPID) Gross Margin Growth (3y) (2023 - 2026)

Rapid Micro Biosystems (RPID) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 63.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -324.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 56.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 311.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -164.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Rapid Micro Biosystems 90.41 Mn 80.98 Mn 371,000.00 356.00

Historic Data

Download Data
DateValue
Mar 31, 2026 356.00
Dec 31, 2025 38,003.00
Sep 30, 2025 -3,076.00
Jun 30, 2025 2,480.00
Mar 31, 2025 -5,290.00
Dec 31, 2024 -15,192.00
Sep 30, 2024 -4,791.00
Jun 30, 2024 -6,660.00
Mar 31, 2024 1,812.00
Dec 31, 2023 24,868.00
Sep 30, 2023 -8,501.00
Jun 30, 2023 -2,341.00